Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages

Tumor necrosis factor α (TNFα) drives the pathophysiology of human autoimmune diseases and consequently, neutralizing antibodies (Abs) or Ab-derived molecules directed against TNFα are essential therapeutics. As treatment with several TNFα blockers has been reported to entail a higher risk of infect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Arens, Katharina, Filippis, Christodoulos, Kleinfelder, Helen, Goetzee, Arthur, Reichmann, Gabriele, Crauwels, Peter, Waibler, Zoe, Bagola, Katrin, van Zandbergen, Ger
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079256/
https://ncbi.nlm.nih.gov/pubmed/30108591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01772
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados